CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Retained Earnings
Beginning balance (in shares) at Dec. 31, 2022		15,523,300
Beginning balance at Dec. 31, 2022	$ 694,240	$ 155	$ 471,300	$ 0	$ 222,785
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	9,571		9,571
Restricted stock issuance, net (in shares)		246,263
Restricted stock issuance, net	0	$ 3	(3)
Stock issuance for acquisitions (in shares)		121,345
Stock issuance for acquisitions	14,471	$ 1	14,470
Reclassification of liability-classified awards to equity-classified awards	1,697		1,697
Other comprehensive loss	(191)			(191)
Net income	21,360				21,360
Ending balance (in shares) at Jul. 01, 2023		15,890,908
Ending balance at Jul. 01, 2023	741,148	$ 159	497,035	(191)	244,145
Beginning balance (in shares) at Apr. 01, 2023		15,708,193
Beginning balance at Apr. 01, 2023	719,870	$ 157	490,981	0	228,732
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	4,359		4,359
Restricted stock issuance, net (in shares)		182,715
Restricted stock issuance, net	0	$ 2	(2)
Reclassification of liability-classified awards to equity-classified awards	1,697		1,697
Other comprehensive loss	(191)			(191)
Net income	15,413				15,413
Ending balance (in shares) at Jul. 01, 2023		15,890,908
Ending balance at Jul. 01, 2023	$ 741,148	$ 159	497,035	(191)	244,145
Beginning balance (in shares) at Dec. 30, 2023	15,895,255	15,895,255
Beginning balance at Dec. 30, 2023	$ 775,795	$ 159	508,256	(18)	267,398
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	12,179		12,179
Restricted stock issuance, net (in shares)		337,894
Restricted stock issuance, net	0	$ 4	(4)
Stock issuance for acquisitions (in shares)		41,428
Stock issuance for acquisitions	3,958		3,958
Reclassification of liability-classified awards to equity-classified awards	2,429		2,429
Payment of contingent consideration with common stock (in shares)		6,024
Payment of contingent consideration with common stock	600		600
Other comprehensive loss	(677)			(677)
Net income	$ 8,315				8,315
Ending balance (in shares) at Jun. 29, 2024	16,280,601	16,280,601
Ending balance at Jun. 29, 2024	$ 802,599	$ 163	527,418	(695)	275,713
Beginning balance (in shares) at Mar. 30, 2024		15,953,908
Beginning balance at Mar. 30, 2024	783,280	$ 160	515,833	(519)	267,806
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	6,460		6,460
Restricted stock issuance, net (in shares)		297,892
Restricted stock issuance, net	0	$ 3	(3)
Stock issuance for acquisitions (in shares)		22,777
Stock issuance for acquisitions	2,099		2,099
Reclassification of liability-classified awards to equity-classified awards	2,429		2,429
Payment of contingent consideration with common stock (in shares)		6,024
Payment of contingent consideration with common stock	600		600
Other comprehensive loss	(176)			(176)
Net income	$ 7,907				7,907
Ending balance (in shares) at Jun. 29, 2024	16,280,601	16,280,601
Ending balance at Jun. 29, 2024	$ 802,599	$ 163	$ 527,418	$ (695)	$ 275,713